BioLife Solutions, Inc. (BLFS) Stock Forecast
BLFS analyst forecast
as of October 17, 2026- Analyst consensus
- —
- Price target
- $31.00 average of analyst targets
- Upside to target
- −19.7% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.01
- 52-week range
- $18.15 – $39.22
BLFS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BLFS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.07 | $0.07 | $0.07 | $0.04 | +66.9% | 1 |
| Current fiscal year (2026) | $0.25 | $0.25 | $0.25 | $0.13 | +91.9% | 1 |
| Next fiscal year (2027) | $0.33 | $0.33 | $0.33 | $0.25 | +32.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BLFS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $29.3M | $29.2M | $29.5M | +4.5% | 3 |
| Current fiscal year (2026) | $115.3M | $114.7M | $116.5M | +19.8% | 3 |
| Next fiscal year (2027) | $133.9M | $132.0M | $135.7M | +16.2% | 5 |
BLFS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BLFS revenue: reported and forecast
BLFS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.04 | $0.07 | $0.07 | $0.07 | $0.07 | +75.0% | 0 up · 0 down |
| Current fiscal year (2026) | $0.25 | $0.25 | $0.25 | $0.25 | $0.25 | 0.0% | 0 up · 1 down |
| Next fiscal year (2027) | $0.29 | $0.29 | $0.29 | $0.33 | $0.33 | +13.8% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BLFS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BLFS beat in 10 of 12.
What analysts expect from BLFS
The average price target is $31.00, 19.7% below the latest close of $38.61. Analysts expect earnings of $0.25 per share for 2026, +91.9% from a year earlier. For 2027 the average estimate is $0.33 per share on revenue of $133.9 million. BioLife Solutions beat the EPS estimate in 10 of the last 12 quarters.
Related: BLFS income statement, BLFS key metrics, BLFS chart. See the BLFS stock overview for the latest quote and news.
BLFS forecast FAQ
What is BioLife Solutions's price target?
The average analyst price target for BioLife Solutions is $31.00, 19.7% below the latest close of $38.61.
What is BioLife Solutions's EPS forecast?
Analysts forecast $0.25 per share for 2026 (range $0.25 to $0.25); for 2027 the estimate is $0.33.
What is BioLife Solutions's revenue forecast?
The average revenue estimate for 2026 is $115.3 million, growth of 19.8%; for 2027 it is $133.9 million.
When does BioLife Solutions report earnings?
BioLife Solutions is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.01.
Does BioLife Solutions usually beat earnings estimates?
BioLife Solutions reported EPS at or above the analyst estimate in 10 of the last 12 quarters.